Evolent Health (EVH) PT Raised to $9.50 at Goldman Sachs
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.41 -5.77%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Goldman Sachs analyst Robert Jones raised the price target on Evolent Health (NYSE: EVH) to $9.50 (from $8.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Evolent Health (EVH) PT Raised to $6 at TD Cowen
- Citi Upgrades Insurance Australia Group Ltd. (IAG:AU) (IAUGD) to Buy
- Sumco Corp (3436:JP) (SUOPY) PT Raised to JPY4,500 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
